Background: Alprostadil and sildenafil are known vasodilators used independently to improve flap survival in animal models. In this study, we investigate whether these agents act synergistically to decrease flap necrosis in rat models. Methods: After acclimation period, 4 groups of 10 male white rats were given a modified McFarlane skin flap. The postoperative treatment included saline control (Group A), sildenafil citrate-only (Group B), alprostadil-only (Group C), and both sildenafil and alprostadil (Group D). The flaps were observed on postoperative days 1, 3, 5 and 7. The animals were euthenized on postoperative day 7, and the flaps were evaluated for inflammation and neovascularization. Results: At each observation, the mean necrotic index was significantly lower for all three treatment groups (Groups A, B, C) and was the lowest for the combined treatment group. On histologic evaluations, combined treatment was associated with decreased inflammation and increased capillary vessel formation, when compared with control group. Conclusion: Both sildenafil-only and alprostadil treatments were independently associated with increased flap survival rate. Sildenafil citrate and alprostadil had a synergistic effect in increasing flap survival rate.
INTRODUCTION
Flap necrosis is a physiologic consequence of prolonged ischemia in a surgical flap. Regardless of causes, partial or whole flap necrosis is regarded as a major complication and such events can result in wound dehiscence, infection, delayed healing, and fistula formation. These complications often prolong postoperative hospitalization and may require additional surgical management with less-than-optimal outcomes. 74 in treating erectile dysfunction.
This animal study was designed to compare flap survivability between sildenafil citrate and PGE1 and to evaluate whether these effects are synergistic between the two agents.
METHODS

Flap creation and postoperative management of rats
Upon approved from the institutional animal experimentation ethics review committee, Sprague-Dawley rats were obtained (n=40). The rats were 12 weeks old, weighed between 300 to 400 g, and given a week of adaptation with ad lib water and feed.
On the day of operation, each rat was intramuscularly injected with 0.1 mL/100 g of tiletamine and zolazepam mixture (Virbac Korea Co., Seoul, Korea). Once under full anesthesia, the back was prepared with an electric shaver, and the dorsal surgical site was Co., Seoul, Korea) was intramuscularly injected for three days postoperatively (5 mg/kg/day).
The rats were randomly assigned into four groups of 10 animals each. Group A served as control and was administered with oral an intravenous saline solution. Group B was administered with oral saline solution and intravenous alprostadil (Eglandin, Mitsubishi Tanabe Pharma Co., Ltd., Seoul, Korea). Group C was administered with oral sildenafil citrate (Viagra, Pfizer Australia Pty Ltd., West Ryde, Australia) and intravenous saline solution.
Group D was administered with oral sildenafil citrate and intravenous alprostadil.
For Groups C and D, oral sildenafil table (100 mg/tab) was ground with pestle and mortar, dissolved in 10 mL saline solution, and fed through a flexible gastric tube (20 mg/kg/day) for 7 days. For Groups B and D, alprostadil (10 µg/2 mL ampoule) was diluted to a concentration of 1 µg/mL. After warming up the tail with infrared lamp to 30°C-35°C, the solution was injected into the dilated vein through a 24-gauge needle (1 µg/kg/ day) for 7 days.
Photographic flap necrosis evaluation
The flaps were photographed on postoperative days 1, 3, 5, and 7.
The photographs were loaded into Image J software (National Institute of Health) and evaluated by three observers who were blinded to the treatment regimen. Each flap was evaluated for the extent of necrosis as a percentage of total flap area (necrotic index, NI). The values were averaged between the observers and compared across the observations (Fig. 1 ).
Tissue specimen preparation and histological observation
In each group, a randomly selected animal was sacrificed on postoperative days 1, 3, and 5 for histologic evaluation. All of the remaining rats were euthenized on postoperative day 7. The flaps were harvested and fixed in a 10% neutral formalin solution for two days. After paraffin fixation, 2-cm sections were stained with H&E stain. The specimens were examined at 10, 20, and 200 magnifications and were evaluated for epidermal exfoliation due to necrosis, acute and chronic inflammation, granulation tissue formation, and fibrosis. Also, neovascularization was quantified by the number of new capillaries present within a 200× field.
Statistical analysis
The SPSS ver. 22.0 package was used for statistical analysis of the NI. Results were expressed in means and standard deviations. The values were compared across the four groups using one-way analysis of variance (ANOVA). Post-hoc analyses were used for multicomparison through the least significance difference method.
Statistical significance was accepted for p<0.05.
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RESULTS
Photographic evaluation
All of the animals survived through the study duration, except for those sacrificed for early histologic evaluation. Overall, the control group of rats showed the highest average areas of flap necrosis at each evaluation. There were no significant patterns in maximum and minimum necrosis areas with respect to the administration of sildenafil or alprostadil (Table 1) .
Histological findings
Epidermal exfoliation and flap detachment was greater in the Fig. 3 ). The degree of lymphocyte infiltration and fibrosis in each group showed no significant differences. +, few; ++, moderately; +++: much.
Statistical analysis of flap necrosis area
The mean NI was compared across the four groups using one-way ANOVA. The mean flap necrosis area rate was lowest in combined treatment (Group D, 31.0%) and was highest in control animals (Group A, 56.7%) throughout the experiment (p-value<0.05).
Comparing single-agent treatments, the mean NI was higher for alprostadil-only administration (Group C) than for sildenafil-only administration (Group B), though this was not statistically significant. Aprostadil-only administration was associated with significantly higher mean NI, compared to combined treatment (p-value <0.05). Sildenafil-only administration was also associated with higher mean NI compared to combined treatment, though this was not statistically significant observation (Table 3) . 78 tivated in the lung, the principle active component of apostil is
Lipo-PGE1, which uses micro-fat globules as carriers and has a longer half-life in the body.
Sildenafil citrate is a phospodiesterase-5 inhibitor and prevents degradation of cyclic GMP within the nitrogen guanylate cyclase pathway, which subsequently prevents NO depletion [8] . Tsai et al. [9] demonstrated that intraperitoneal administration of 10 mg/ Kg/day of sildenafil citrate was effective in improving the flap survival rate in rats. In a similar study using the rat model, Sarifakioglu et al. [10] found a dose-dependent relationship between sildenafil citrate, with higher doses associated with improve flap survival.
The current study investigated whether the combination of al- While sildenafil citrate was found to be very effective in enhancing the flap survival rate in this study, continuous administration can result in undesirable symptoms. Such side effects include headache, hot flush, nasal congestion, and dyspepsia, all of which are primarily attributed to vasodilation characterized by sildenafil citrate [11] . It can also inhibit the functions of platelet, prevent platelet aggregation, and cause gastric ulcer. In addition, it can be hazardous for heart disease patients since it may weaken cyclic adenosine monophosphate-specific PDE isoform-3 involved in cardiac constriction, dilate blood vessels, and decrease blood pressure abruptly [12] . It is necessary to conduct further research to determine a dose and concentration of sildenafil citrate that can maximize the flap survival rate while preventing systemic adverse effects and to identify long-term effects and complications of sildenafil administration combined with alprostadil and other agents.
In this study, sildenafil citrate and alprostadil were used in sin- 
